Keyphrases
Cardiac Disease
14%
Cardiac Fibrosis
14%
Cardiomyocytes
14%
Diastolic Dysfunction
42%
Dipeptidyl peptidase-4 (DPP-4)
57%
Four-level
14%
Hyperglycemia
14%
Isoform Switching
14%
Left Ventricular Function
100%
Left Ventricular Relaxation
14%
Left Ventricular Stiffness
57%
Linagliptin
100%
Metabolic Syndrome
71%
Obesity
14%
Passive Stiffness
14%
Phosphorylation
28%
Placebo
14%
Simultaneous Administration
14%
Titin
100%
Titin Isoforms
28%
ZSF1 Rat
28%
INIS
administration
20%
cleavage
100%
diet
20%
diseases
20%
fibrosis
20%
humans
20%
hyperglycemia
20%
in vitro
20%
levels
40%
obesity
20%
patients
20%
phosphorylation
40%
rats
40%
relaxation
40%
stiffness
100%
Pharmacology, Toxicology and Pharmaceutical Science
Connectin
100%
Diastolic Dysfunction
42%
Dipeptidyl Peptidase IV
28%
Dipeptidyl Peptidase IV Inhibitor
14%
Heart Disease
14%
Heart Muscle Fibrosis
14%
Hyperglycemia
14%
Hyperlipidemia
14%
Linagliptin
100%
Metabolic Syndrome X
71%
Placebo
14%
ZSF1 Rat
28%
Medicine and Dentistry
Cardiac Fibrosis
14%
Cardiac Muscle Cell
14%
Diastolic Dysfunction
42%
Dipeptidyl Peptidase IV
28%
Dipeptidyl Peptidase-4 Inhibitor
14%
Heart Disease
14%
Hyperglycemia
14%
Hyperlipidemia
14%
In Vitro
14%
Linagliptin
100%
Metabolic Syndrome
71%
Placebo
14%
Titin
100%